Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.03 USD | +0.12% | -0.42% | -17.26% |
01:55pm | Argus Cuts Price Target on Gilead Sciences to $75 From $85 | MT |
Apr. 22 | Cantor Fitzgerald Adjusts Gilead Sciences' Price Target to $75 From $78, Maintains Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.26% | 83.48B | |
+27.92% | 659B | |
+27.68% | 557B | |
-4.59% | 359B | |
+16.38% | 322B | |
+9.39% | 297B | |
+6.30% | 215B | |
+4.80% | 210B | |
-6.05% | 200B | |
-8.58% | 149B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Gilead's Trodelvy 'Significantly Improves' Overall Survival in Pre-Treated Metastatic Breast Cancer Patients -- Shares Rise